Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
Go back to Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 279.44 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $279.44 | 52 Week High | $139.79 | |||
| Open | $279.44 | 52 Week Low | $82.07 | |||
| Day High | $279.44 | P/E | 649.86 | |||
| Day Low | $279.44 | EPS | $0.43 | |||
| Volume | 58 | |||||
| XOMA (NASDAQ: XOMA) | Delayed: 41.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.95 | 52 Week High | $7.33 | |||
| Open | $41.95 | 52 Week Low | $0.34 | |||
| Day High | $41.95 | P/E | N/A | |||
| Day Low | $41.95 | EPS | $-0.73 | |||
| Volume | 2 | |||||
| (NASDAQ: XOMAO) | Delayed: 25.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.43 | 52 Week High | $ | |||
| Open | $25.43 | 52 Week Low | $ | |||
| Day High | $25.43 | P/E | N/A | |||
| Day Low | $25.43 | EPS | $ | |||
| Volume | 1 | |||||
| (NASDAQ: XOMAP) | Delayed: 25.48 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.48 | 52 Week High | $ | |||
| Open | $25.48 | 52 Week Low | $ | |||
| Day High | $25.48 | P/E | N/A | |||
| Day Low | $25.48 | EPS | $ | |||
| Volume | 23,915 | |||||

